BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9468467)

  • 1. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease.
    Mayeux R; Saunders AM; Shea S; Mirra S; Evans D; Roses AD; Hyman BT; Crain B; Tang MX; Phelps CH
    N Engl J Med; 1998 Feb; 338(8):506-11. PubMed ID: 9468467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's Disease.
    Welsh-Bohmer KA; Gearing M; Saunders AM; Roses AD; Mirra S
    Ann Neurol; 1997 Sep; 42(3):319-25. PubMed ID: 9307253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].
    Rosich-Estragó M; Figuera-Terré L; Mulet-Pérez B; Arrufat-Cardús MT; Pascual San Emeterio A; Arbeola-Rigau I; Labad-Alquézar A; Vilella-Cuadrada E
    Rev Neurol; 2004 May 1-15; 38(9):801-7. PubMed ID: 15152345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE genotype in the diagnosis of Alzheimer's disease in patients with cognitive impairment.
    Sun X; Nicholas J; Walker A; Wagner MT; Bachman D
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):315-20. PubMed ID: 22815080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF beta-amyloid 1-42 and tau in Tunisian patients with Alzheimer's disease: the effect of APOE epsilon4 allele.
    Smach MA; Charfeddine B; Lammouchi T; Harrabi I; Ben Othman L; Dridi H; Bennamou S; Limem K
    Neurosci Lett; 2008 Aug; 440(2):145-9. PubMed ID: 18555606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET.
    Drzezga A; Grimmer T; Riemenschneider M; Lautenschlager N; Siebner H; Alexopoulus P; Minoshima S; Schwaiger M; Kurz A
    J Nucl Med; 2005 Oct; 46(10):1625-32. PubMed ID: 16204712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
    Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
    Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease.
    Stern Y; Brandt J; Albert M; Jacobs DM; Liu X; Bell K; Marder K; Sano M; Albert S; Del-Castillo Castenada C; Bylsma F; Tycko B; Mayeux R
    Ann Neurol; 1997 May; 41(5):615-20. PubMed ID: 9153523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE-epsilon4 and APOE -491A polymorphisms in individuals with subjective memory loss.
    Laws SM; Clarnette RM; Taddei K; Martins G; Paton A; Hallmayer J; Almeida OP; Groth DM; Gandy SE; Förstl H; Martins RN
    Mol Psychiatry; 2002; 7(7):768-75. PubMed ID: 12192621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Middle-aged children of persons with Alzheimer's disease: APOE genotypes and cognitive function in the Wisconsin Registry for Alzheimer's Prevention.
    Sager MA; Hermann B; La Rue A
    J Geriatr Psychiatry Neurol; 2005 Dec; 18(4):245-9. PubMed ID: 16306248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Apolipoprotein E polymorphism and Alzheimer disease].
    van der Weide J; Steijns LS; Teepen JL; Noback WJ; Klaverwijden G
    Tijdschr Gerontol Geriatr; 1996 Apr; 27(2):73-7. PubMed ID: 8669075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of the APOE-4 allele in Alzheimer's disease and its variation with age in Asturias (Spain)].
    Alvarez V; Alvarez R; Peña J; Lahoz CH; Martínez C; Menéndez-Guisasola L; Salas-Puig J; Morís G; Uría D; Menes BB; Ribacoba R; Vidal JA; Coto E
    Med Clin (Barc); 1999 Oct; 113(12):441-3. PubMed ID: 10570509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
    Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
    Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EEG functional connectivity and ApoE genotype in Alzheimer's disease and controls.
    Kramer G; van der Flier WM; de Langen C; Blankenstein MA; Scheltens P; Stam CJ
    Clin Neurophysiol; 2008 Dec; 119(12):2727-32. PubMed ID: 18848805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series.
    Tsuang D; Larson EB; Bowen J; McCormick W; Teri L; Nochlin D; Leverenz JB; Peskind ER; Lim A; Raskind MA; Thompson ML; Mirra SS; Gearing M; Schellenberg GD; Kukull W
    Arch Neurol; 1999 Dec; 56(12):1489-95. PubMed ID: 10593304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presymptomatic apolipoprotein E genotyping for Alzheimer's disease risk assessment and prevention.
    Schipper HM
    Alzheimers Dement; 2011 Jul; 7(4):e118-23. PubMed ID: 21665554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.